 Avner Meoded
Concepts (209)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diffusion Tensor Imaging | 21 | 2023 | 24 | 5.760 |
Why?
| | Brain | 21 | 2023 | 79 | 5.750 |
Why?
| | Magnetic Resonance Imaging | 25 | 2023 | 122 | 3.150 |
Why?
| | Connectome | 5 | 2020 | 5 | 2.880 |
Why?
| | Neuroimaging | 13 | 2021 | 18 | 2.740 |
Why?
| | Humans | 64 | 2024 | 6929 | 1.830 |
Why?
| | Eye Abnormalities | 4 | 2022 | 6 | 1.790 |
Why?
| | Kidney Diseases, Cystic | 4 | 2022 | 7 | 1.780 |
Why?
| | White Matter | 4 | 2022 | 6 | 1.680 |
Why?
| | Abnormalities, Multiple | 4 | 2022 | 36 | 1.660 |
Why?
| | Corpus Callosum | 3 | 2022 | 5 | 1.520 |
Why?
| | Cerebellum | 9 | 2022 | 13 | 1.430 |
Why?
| | Child | 39 | 2024 | 3348 | 1.320 |
Why?
| | Nerve Net | 2 | 2020 | 2 | 1.220 |
Why?
| | Medulloblastoma | 4 | 2024 | 10 | 1.180 |
Why?
| | Brain Ischemia | 6 | 2022 | 7 | 1.170 |
Why?
| | Diffusion Magnetic Resonance Imaging | 8 | 2023 | 9 | 1.140 |
Why?
| | Female | 32 | 2024 | 3534 | 1.130 |
Why?
| | Stroke | 5 | 2022 | 22 | 1.060 |
Why?
| | Male | 33 | 2024 | 3367 | 1.050 |
Why?
| | Nervous System Malformations | 3 | 2021 | 6 | 1.020 |
Why?
| | Nerve Degeneration | 2 | 2016 | 2 | 1.000 |
Why?
| | Motor Neuron Disease | 2 | 2014 | 2 | 0.990 |
Why?
| | Child, Preschool | 18 | 2024 | 1562 | 0.990 |
Why?
| | Agenesis of Corpus Callosum | 2 | 2014 | 2 | 0.900 |
Why?
| | Spinal Dysraphism | 1 | 2022 | 8 | 0.860 |
Why?
| | Walking | 1 | 2022 | 35 | 0.840 |
Why?
| | Tomography, X-Ray Computed | 9 | 2022 | 130 | 0.830 |
Why?
| | Infratentorial Neoplasms | 2 | 2020 | 2 | 0.820 |
Why?
| | Prenatal Diagnosis | 2 | 2011 | 14 | 0.800 |
Why?
| | Astrocytoma | 2 | 2020 | 5 | 0.740 |
Why?
| | Postoperative Complications | 3 | 2024 | 202 | 0.730 |
Why?
| | Brain Mapping | 3 | 2020 | 10 | 0.680 |
Why?
| | Neural Pathways | 3 | 2017 | 5 | 0.660 |
Why?
| | Cerebellar Diseases | 5 | 2022 | 5 | 0.650 |
Why?
| | Brain Diseases | 3 | 2021 | 6 | 0.640 |
Why?
| | Cerebral Cortex | 2 | 2014 | 6 | 0.630 |
Why?
| | Pediatrics | 1 | 2020 | 183 | 0.600 |
Why?
| | Skull | 5 | 2021 | 12 | 0.600 |
Why?
| | Craniocerebral Trauma | 2 | 2019 | 19 | 0.570 |
Why?
| | Cerebellar Neoplasms | 3 | 2024 | 5 | 0.570 |
Why?
| | Hemispherectomy | 1 | 2016 | 1 | 0.550 |
Why?
| | Adolescent | 17 | 2024 | 2183 | 0.510 |
Why?
| | Brain Neoplasms | 4 | 2020 | 44 | 0.500 |
Why?
| | Infant, Newborn, Diseases | 2 | 2012 | 30 | 0.490 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2014 | 3 | 0.490 |
Why?
| | Mood Disorders | 1 | 2014 | 7 | 0.490 |
Why?
| | Retina | 4 | 2022 | 5 | 0.470 |
Why?
| | Olivary Nucleus | 1 | 2013 | 1 | 0.460 |
Why?
| | Cerebral Veins | 1 | 2013 | 1 | 0.460 |
Why?
| | Spinal Cord | 2 | 2023 | 6 | 0.450 |
Why?
| | Mutism | 2 | 2024 | 2 | 0.450 |
Why?
| | Magnetic Resonance Angiography | 1 | 2013 | 9 | 0.450 |
Why?
| | Brain Stem | 6 | 2022 | 6 | 0.450 |
Why?
| | Imaging, Three-Dimensional | 2 | 2013 | 18 | 0.440 |
Why?
| | Anisotropy | 7 | 2017 | 7 | 0.420 |
Why?
| | Hydrocephalus | 2 | 2022 | 8 | 0.410 |
Why?
| | Tectorial Membrane | 1 | 2011 | 1 | 0.400 |
Why?
| | Leukoencephalopathies | 1 | 2011 | 2 | 0.400 |
Why?
| | Infant | 11 | 2021 | 1449 | 0.380 |
Why?
| | Infant, Newborn | 9 | 2022 | 826 | 0.380 |
Why?
| | Lymphoma | 2 | 2023 | 9 | 0.360 |
Why?
| | Middle Aged | 6 | 2020 | 645 | 0.340 |
Why?
| | Image Interpretation, Computer-Assisted | 4 | 2017 | 22 | 0.330 |
Why?
| | Neurodevelopmental Disorders | 2 | 2020 | 23 | 0.320 |
Why?
| | Retrospective Studies | 9 | 2022 | 1337 | 0.320 |
Why?
| | Sinus Thrombosis, Intracranial | 2 | 2020 | 2 | 0.290 |
Why?
| | Pancreatectomy | 2 | 2016 | 5 | 0.280 |
Why?
| | Pons | 2 | 2017 | 2 | 0.270 |
Why?
| | Leukodystrophy, Globoid Cell | 2 | 2016 | 2 | 0.260 |
Why?
| | Reproducibility of Results | 4 | 2013 | 198 | 0.250 |
Why?
| | Pyramidal Tracts | 2 | 2014 | 2 | 0.240 |
Why?
| | Adaptation, Psychological | 1 | 2024 | 38 | 0.230 |
Why?
| | Image Enhancement | 3 | 2013 | 14 | 0.230 |
Why?
| | Spinal Cord Neoplasms | 1 | 2023 | 3 | 0.230 |
Why?
| | Syndrome | 2 | 2022 | 34 | 0.230 |
Why?
| | Pregnancy | 3 | 2021 | 212 | 0.230 |
Why?
| | Sensitivity and Specificity | 3 | 2013 | 151 | 0.230 |
Why?
| | Heart Transplantation | 1 | 2023 | 17 | 0.230 |
Why?
| | Thrombophilia | 1 | 2022 | 2 | 0.220 |
Why?
| | Hemostatics | 1 | 2022 | 3 | 0.220 |
Why?
| | Ascaridoidea | 1 | 2022 | 1 | 0.220 |
Why?
| | Ascaridida Infections | 1 | 2022 | 1 | 0.220 |
Why?
| | Meningitis | 1 | 2022 | 3 | 0.220 |
Why?
| | Language Development Disorders | 1 | 2022 | 3 | 0.210 |
Why?
| | Intracranial Hemorrhages | 2 | 2012 | 7 | 0.210 |
Why?
| | Fourth Ventricle | 1 | 2022 | 1 | 0.210 |
Why?
| | Brain Injuries | 2 | 2012 | 8 | 0.210 |
Why?
| | Zika Virus Infection | 1 | 2021 | 1 | 0.210 |
Why?
| | Zika Virus | 1 | 2021 | 1 | 0.210 |
Why?
| | Microcephaly | 1 | 2021 | 5 | 0.200 |
Why?
| | Diagnosis, Differential | 4 | 2020 | 78 | 0.200 |
Why?
| | Supratentorial Neoplasms | 1 | 2020 | 1 | 0.190 |
Why?
| | Ganglioglioma | 1 | 2020 | 1 | 0.190 |
Why?
| | Intracranial Thrombosis | 1 | 2020 | 3 | 0.190 |
Why?
| | Paranasal Sinuses | 1 | 2020 | 1 | 0.180 |
Why?
| | Sinusitis | 1 | 2020 | 5 | 0.180 |
Why?
| | Erdheim-Chester Disease | 1 | 2020 | 1 | 0.180 |
Why?
| | Thrombosis | 1 | 2020 | 16 | 0.180 |
Why?
| | Nervous System Diseases | 1 | 2020 | 13 | 0.180 |
Why?
| | Hematoma, Subdural | 1 | 2019 | 4 | 0.180 |
Why?
| | Adult | 4 | 2020 | 1199 | 0.170 |
Why?
| | Child Abuse | 1 | 2019 | 47 | 0.160 |
Why?
| | Occipital Bone | 1 | 2017 | 1 | 0.150 |
Why?
| | Allografts | 1 | 2017 | 7 | 0.150 |
Why?
| | Ilium | 1 | 2017 | 3 | 0.150 |
Why?
| | Glioma | 2 | 2015 | 27 | 0.150 |
Why?
| | Bone Transplantation | 1 | 2017 | 9 | 0.150 |
Why?
| | Cervical Vertebrae | 1 | 2017 | 7 | 0.150 |
Why?
| | Spinal Fusion | 1 | 2017 | 18 | 0.150 |
Why?
| | Receptors, Immunologic | 1 | 2017 | 11 | 0.150 |
Why?
| | Pancreaticojejunostomy | 1 | 2016 | 1 | 0.140 |
Why?
| | Pancreatitis, Chronic | 1 | 2016 | 1 | 0.140 |
Why?
| | Pancreas Transplantation | 1 | 2016 | 2 | 0.140 |
Why?
| | Nerve Tissue Proteins | 1 | 2017 | 25 | 0.140 |
Why?
| | Pancreas | 1 | 2016 | 10 | 0.140 |
Why?
| | Pancreatic Neoplasms | 1 | 2016 | 13 | 0.140 |
Why?
| | Biomarkers | 1 | 2016 | 132 | 0.140 |
Why?
| | Practice Guidelines as Topic | 1 | 2016 | 104 | 0.140 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2017 | 17 | 0.140 |
Why?
| | Linear Models | 1 | 2016 | 57 | 0.130 |
Why?
| | Mutation | 1 | 2017 | 213 | 0.130 |
Why?
| | Multimodal Imaging | 1 | 2015 | 2 | 0.130 |
Why?
| | Positron-Emission Tomography | 1 | 2015 | 3 | 0.130 |
Why?
| | Hypoxia-Ischemia, Brain | 2 | 2012 | 2 | 0.130 |
Why?
| | Follow-Up Studies | 2 | 2017 | 329 | 0.130 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2014 | 4 | 0.120 |
Why?
| | Achondroplasia | 1 | 2014 | 1 | 0.120 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2014 | 1 | 0.120 |
Why?
| | Arnold-Chiari Malformation | 1 | 2014 | 1 | 0.120 |
Why?
| | Spinocerebellar Tracts | 1 | 2014 | 1 | 0.120 |
Why?
| | Prevalence | 1 | 2014 | 150 | 0.120 |
Why?
| | Edema | 1 | 2013 | 7 | 0.120 |
Why?
| | Pantothenate Kinase-Associated Neurodegeneration | 1 | 2013 | 1 | 0.120 |
Why?
| | Hypertrophy | 1 | 2013 | 4 | 0.120 |
Why?
| | Neoplasm Grading | 1 | 2013 | 20 | 0.110 |
Why?
| | Cerebrovascular Circulation | 1 | 2013 | 2 | 0.110 |
Why?
| | Blood Flow Velocity | 1 | 2013 | 8 | 0.110 |
Why?
| | Radiculopathy | 1 | 2013 | 1 | 0.110 |
Why?
| | Brachial Plexus | 1 | 2013 | 3 | 0.110 |
Why?
| | Nerve Fibers | 1 | 2013 | 1 | 0.110 |
Why?
| | Pilot Projects | 1 | 2013 | 114 | 0.110 |
Why?
| | Echoencephalography | 1 | 2012 | 1 | 0.110 |
Why?
| | Brain Diseases, Metabolic, Inborn | 1 | 2012 | 1 | 0.110 |
Why?
| | Premature Birth | 1 | 2012 | 7 | 0.110 |
Why?
| | Neonatal Screening | 1 | 2012 | 7 | 0.110 |
Why?
| | Brain Death | 1 | 2012 | 3 | 0.100 |
Why?
| | Cranial Fossa, Posterior | 1 | 2011 | 1 | 0.100 |
Why?
| | Skull Base Neoplasms | 1 | 2011 | 2 | 0.100 |
Why?
| | Encephalocele | 1 | 2011 | 4 | 0.100 |
Why?
| | Infant, Premature, Diseases | 1 | 2012 | 23 | 0.100 |
Why?
| | Subtraction Technique | 1 | 2011 | 1 | 0.100 |
Why?
| | Ultrasonography, Prenatal | 1 | 2011 | 11 | 0.100 |
Why?
| | Diagnostic Imaging | 1 | 2011 | 16 | 0.100 |
Why?
| | Anencephaly | 1 | 2011 | 1 | 0.100 |
Why?
| | Infant, Premature | 1 | 2012 | 86 | 0.100 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2010 | 1 | 0.090 |
Why?
| | Meningioma | 1 | 2010 | 2 | 0.090 |
Why?
| | Meningeal Neoplasms | 1 | 2010 | 4 | 0.090 |
Why?
| | Carcinoma, Renal Cell | 1 | 2010 | 2 | 0.090 |
Why?
| | Young Adult | 3 | 2020 | 641 | 0.090 |
Why?
| | Kidney Neoplasms | 1 | 2010 | 11 | 0.090 |
Why?
| | Fluorodeoxyglucose F18 | 2 | 2023 | 5 | 0.090 |
Why?
| | Prognosis | 2 | 2020 | 216 | 0.080 |
Why?
| | Animals | 2 | 2022 | 741 | 0.070 |
Why?
| | Case-Control Studies | 2 | 2020 | 216 | 0.070 |
Why?
| | Prospective Studies | 2 | 2020 | 547 | 0.060 |
Why?
| | Neuropsychological Tests | 1 | 2024 | 15 | 0.060 |
Why?
| | Emotions | 1 | 2024 | 21 | 0.060 |
Why?
| | Biopsy | 1 | 2023 | 63 | 0.060 |
Why?
| | Texas | 1 | 2022 | 21 | 0.050 |
Why?
| | Hospitals | 1 | 2022 | 36 | 0.050 |
Why?
| | Research | 1 | 2022 | 12 | 0.050 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2022 | 57 | 0.050 |
Why?
| | Visual Pathways | 1 | 2021 | 1 | 0.050 |
Why?
| | Age Factors | 2 | 2012 | 211 | 0.050 |
Why?
| | Prefrontal Cortex | 1 | 2020 | 4 | 0.050 |
Why?
| | Nasopharyngeal Neoplasms | 1 | 2020 | 1 | 0.050 |
Why?
| | Herpesvirus 4, Human | 1 | 2020 | 5 | 0.050 |
Why?
| | Peripheral Nervous System Diseases | 1 | 2020 | 1 | 0.050 |
Why?
| | Cerebellar Ataxia | 1 | 2020 | 4 | 0.050 |
Why?
| | Aged | 1 | 2020 | 411 | 0.040 |
Why?
| | Risk Factors | 1 | 2020 | 490 | 0.040 |
Why?
| | Transplantation, Autologous | 1 | 2016 | 5 | 0.040 |
Why?
| | Probability | 1 | 2016 | 15 | 0.040 |
Why?
| | Longitudinal Studies | 1 | 2017 | 119 | 0.040 |
Why?
| | Cystadenoma, Serous | 1 | 2016 | 1 | 0.040 |
Why?
| | Neuroendocrine Tumors | 1 | 2016 | 2 | 0.040 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2016 | 4 | 0.040 |
Why?
| | Precancerous Conditions | 1 | 2015 | 6 | 0.030 |
Why?
| | Radiopharmaceuticals | 1 | 2015 | 5 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2015 | 33 | 0.030 |
Why?
| | Early Detection of Cancer | 1 | 2015 | 9 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2015 | 33 | 0.030 |
Why?
| | Asymptomatic Diseases | 1 | 2014 | 5 | 0.030 |
Why?
| | Constriction, Pathologic | 1 | 2014 | 21 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2016 | 649 | 0.030 |
Why?
| | Age of Onset | 1 | 2013 | 28 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2014 | 148 | 0.030 |
Why?
| | Ocular Motility Disorders | 1 | 2013 | 1 | 0.030 |
Why?
| | Scoliosis | 1 | 2013 | 6 | 0.030 |
Why?
| | Muscle Hypotonia | 1 | 2012 | 7 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2013 | 59 | 0.030 |
Why?
| | Ependymoma | 1 | 2011 | 1 | 0.030 |
Why?
| | Medulla Oblongata | 1 | 2011 | 1 | 0.030 |
Why?
| | Fatal Outcome | 1 | 2011 | 6 | 0.020 |
Why?
| | Anemia, Sickle Cell | 1 | 2011 | 17 | 0.020 |
Why?
| | Echocardiography | 1 | 2011 | 93 | 0.020 |
Why?
| | Disease Progression | 1 | 2011 | 110 | 0.020 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|